Imugene Limited (ASX:IMU) is a clinical stage immuno-oncology company involved in developing a range of new and novel immunotherapies that seek to activate a cancer patient’s immune system to detect and eliminate tumours. Over the years, it has grown tremendously to become one of the top three largest biotech companies in Australia.
GET A FREE STOCK REPORT
Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.